Efficacy of different regimens in multibacillary leprosy.
نویسنده
چکیده
The necessity for combined chemotherapy in multi bacillary leprosy has been recognized for about 1 5 years . I-3 It was however entirely unknown how this combined therapy had to be applied, particularly in respect to the drugs to be given, the frequency of their administration and above all the duration of therapy. We have approached the problem on the basis of results obtained in experimental chemotherapy of Mycobacterium leprae infections in mice,41 2 observations made in man 1 31 5 and prospective chemotherapeutic trials in patients . 16-1 9 From studies in mice and man, we know that there are a t present two bactericidal drugs: rifampicin (RMP) and the thioamides (either ethioor prothionamide, ETH or PRO), and two mainly bacteriostatic drugs : dapsone (DDS) and clofazimine (CLO) . RMP is extremely bactericidal, killing about 5 logs of M. leprae after a single dose of 1 500 mg or a few doses of 600 mg. Due to its profound effect on M. leprae, it can also be given intermittently up to once a month8 whereas ETH or PRO when administered less than three times a week, are inactive.9 , l o Dapsone and clofazimine are interchangeable as bacteriostatic drugs, and since they have a different action mechanism they do not show cross-resistance . From what was known in the treatment of tuberculosis, we concluded that what was needed for the treatment of M B leprosy was l ,2 an association of two and preferably three, bactericidal drugs (but only two are available in leprosy) in order to obtain maximal killing of M. leprae; and the addition of a bacteriostatic drug, whose main role would be to prevent the selection of organisms resistant to the bactericidal drugs. In this interpretation of the events occurring during chemotherapy, the use of a second bacteriostatic drug was unnecessary . We therefore used in all our trials DDS in new patients and replaced it by CLO in patients at risk for secondary DDS-resistance, defined as those patients who had been treated with DDS for 5
منابع مشابه
Methods for the classification of leprosy for treatment purposes.
The World Health Organization advocates 2 leprosy treatment regimens on the basis of disease classification (as multibacillary or paucibacillary) by skin lesion count. This method, which, in the Philippines, results in a high prevalence (78%) of patients with multibacillary leprosy, was directly compared with classification using standard histopathological and microbiological criteria in 264 cu...
متن کاملRelapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
The Schieffelin Leprosy Research and Training Center at Karigiri, India participated in several of the World Health Organization (WHO) trials. The first trial on combined therapy in multi-bacillary leprosy was initiated in 1981. The main objectives of this field trial were to evaluate the efficacy of WHO recommended regimens in preventing relapses, especially drug resistance relapses. This pape...
متن کاملNo difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study.
A comparative study was performed on the initial and final bacillary indexes of 213 multibacillary leprosy patients who received 12 doses (Group 1: 128 patients) or 24 doses (Group 2: 85 patients) of multidrug therapy (MDT/WHO) to measure the effectiveness of the two regimens. All patients were evaluated at treatment baseline, 12 months, and 24 months. The reduction in bacillary levels and mean...
متن کاملCombined chemotherapy of multibacillary leprosy patients.
380 multibacillary leprosy patients were treated with combined chemotherapy at Anandaban leprosy hospital in Nepal. The drugs used were Rifampicin, Dapsone, Clofazamine and Iso-prodian. This treatment is modelled on the short course chemotherapy of tuberculosis. A remarkable clinical and bacteriological improvement was observed in all patients. Group A patients were bacteriologically negative a...
متن کاملTreatment of multibacillary leprosy with a regimen of 13 weeks duration.
In a prospective study 559 multibacillary patients in Zaire were treated for 13 weeks with twice weekly rifampicin (600 mg) and daily ethionamide (500 mg) and dapsone (100 mg), 13-RED, or clofazimine (100 mg), 13-REC. The patients were followed for a total of 1418 person years, mean 3.2 years. The incidence of hepatitis was 3.3%. The incidence of relapses was 0.28 per 100 person years. Relapses...
متن کاملRelapse following various types of multidrug therapy in multibacillary leprosy.
One of commonest questions asked by leprosy patients on their completing multidrug therapy (MDT) is, 'Am I cured?' . There are, of course, several different facets to this question, including the risk of subsequent physical deterioration due to damage to anaesthetic hands or feet. But, from the point of view of chemotherapy, the questioner is in effect enquiring whether all the leprosy bacilli ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Leprosy review
دوره 57 Suppl 3 شماره
صفحات -
تاریخ انتشار 1986